Presence of fatty liver and the relationship between alcohol consumption and markers of inflammation

Mediators of Inflammation
Martin KächeleArmin Imhof

Abstract

Background and Aims. Local and systemic inflammation represent a major feature of atherosclerotic cardiovascular disease (CVD) and are also linked to nonalcoholic fatty liver disease (NAFLD). Studies indicate that NAFLD might be a risk factor for CVD whereas low-to-moderate alcohol consumption is associated with lower cardiovascular morbidity and mortality compared to abstainers and heavy drinkers. We hypothesize that FLD interacts with the effect of alcohol intake on markers of inflammation, and thus potentially on cardiovascular risk. Methods and Results. We evaluated alcohol consumption, markers of inflammation and sonographic criteria of FLD in 515 subjects, representing a subsample of a cross-sectional population based study (Echinococcus multilocularis and Internal Diseases in Leutkirch (EMIL) Study). Presence of FLD was markedly reduced in subjects drinking 0-20 g alcohol/d (19%), compared to nondrinkers (35%) and heavy drinkers (34-44.9%). Serum concentrations of inflammatory markers were substantially higher in subjects with FLD. However, presence of FLD showed no effect on the association between alcohol consumption and inflammatory biomarkers. Conclusions. Based on data from a population-based sample, there is no evi...Continue Reading

References

Jan 4, 1986·British Medical Journal·S H SaverymuttuJ D Maxwell
Oct 8, 1999·Journal of Clinical Epidemiology·I R White
Jan 15, 2000·Journal of the American College of Cardiology·J M GazianoJ E Buring
Jan 29, 2003·Circulation·Michelle A AlbertPaul M Ridker
Sep 18, 2003·Addiction Biology·Armin Imhof, Wolfgang Koenig
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Angel BreaEmilio Ros
May 17, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giorgio BedogniStefano Bellentani
Nov 4, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Wolfgang Koenig, Natalie Khuseyinova
Jun 15, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·P LoriaN Carulli
Mar 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Satoshi AkabameToshikazu Yoshikawa
May 6, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Winston DunnJeffrey B Schwimmer
Feb 6, 2009·European Journal of Gastroenterology & Hepatology·Helma P CotrimStephen Caldwell
Mar 27, 2010·Journal of the American College of Cardiology·Simona CostanzoGiovanni de Gaetano
Nov 3, 2010·Journal of Atherosclerosis and Thrombosis·Okan Turgut, Izzet Tandogan
May 20, 2011·Nature·Peter LibbyGöran K Hansson
Mar 1, 2012·World Journal of Gastroenterology : WJG·Vincent BraunersreutherFabrizio Montecucco
Mar 13, 2012·European Heart Journal·Lokpal S BhatiaChristopher D Byrne

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
biopsy

Software Mentioned

SAS

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.